Positron emission tomography and functional characterization of a complete PBR/TSPO knockout
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The evolutionarily conserved peripheral benzodiazepine receptor (PBR), or 18-kDa translocator protein (TSPO), is thought to be essential for cholesterol transport and steroidogenesis, and thus life. TSPO has been proposed as a biomarker of neuroinflammation and a new drug target in neurological diseases ranging from Alzheimer’s disease to anxiety. Here we show that global C57BL/6- Tspo tm1GuWu(GuwiyangWurra) -knockout mice are viable with normal growth, lifespan, cholesterol transport, blood pregnenolone concentration, protoporphyrin IX metabolism, fertility and behaviour. However, while the activation of microglia after neuronal injury appears to be unimpaired, microglia from GuwiyangWurra TSPO knockouts produce significantly less ATP, suggesting reduced metabolic activity. Using the isoquinoline PK11195, the ligand originally used for the pharmacological and structural characterization of the PBR/TSPO, and the imidazopyridines CLINDE and PBR111, we demonstrate the utility of GuwiyangWurra TSPO knockouts to provide robust data on drug specificity and selectivity, both in vitro and in vivo , as well as the mechanism of action of putative TSPO-targeting drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confirmation of global Tspo knockout mice with immunostaining. (a) Anti-TSPO antibody staining showed the presence of TSPO (here shown in the kidney and testis) in the wild-type and absence in the knockout Tspo−/− mice. The slides were the same as previously used for autoradiography with the selective TSPO-binding ligand [3H]PK11195 (Fig. 4). (b) Antibody staining of Tspo+/+ and Tspo+/− macrophages validates mitochondria as the primary site of the TSPO, which is entirely absent in Tspo−/− mice. No obvious difference in intracellular density or distribution of the mitochondria was detected in the Tspo−/− mice (green=TSPO; red=mitochondria; yellow=merged image; blue=nucleus; scale bars: (a) 500 μm and (b) 20 μm).](https://figures.cochat.ai/paper-figures/489dfd31193042a89714e7a6b7fcf5b0/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-2.jpg)
![Figure 3 No constitutive TSPO ligand binding in Tspo−/− mice. (a) Tspo+/+, Tspo+/− and Tspo−/− mice are identical in external appearance and general behaviour. However, in vivo imaging (8 males of the same age for each genotype) with PET/CT using the radioligand [18F]PBR111, the 18F-labelled analogue to [125I]CLINDE, strikingly illustrates that (apart from occasional signals originating from the excretory pathways, such as gut and urinary bladder) Tspo−/− mice show no ligand binding (thus also demonstrating the selectivity of the used ligand), while both Tspo+/+ and Tspo+/− mice have the characteristic distribution of ligand binding, that is, in organs with known high TSPO expression, notably kidney and adrenal gland (green circle). The images are displayed with the colour scaling and are directly comparable (highest values are white). The time-point frame of the PET images is 15–20 min after injection and scaling is 3.8–17.9% ID per cm3. (b) The kinetics of [18F]PBR111, and the displacement of the radioligand after injection (indicated by arrows) with cold PBR111 (1 mM) to establish non-specific binding, demonstrates that Tspo−/− mice do not have specific binding of [18F]PBR111 in any organs, while the ligand kinetic in Tspo+/+ and Tspo+/− mice indicates specific binding (ID= injected dose; n=4 for each genotype; error bars denote standard deviation).](https://figures.cochat.ai/paper-figures/dd26686107704770842176e62bb3174b/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-3.jpg)
![Figure 4 Comparative receptor autoradiography and membrane binding. (a–f) The receptor autoradiographs (16 μm sections) show total binding of [3H]PK11195 (1 nM) and [125I]CLINDE (3 nM) as well as competitive binding with 10 μM unlabelled CLINDE (CB(CL)), PK11195 (CB(PK)) and PBR111 (CB(PBR)) in the spleens (a,b), kidneys (c,d) and testes (e,f) of Tspo+/+, Tspo+/− and Tspo−/− mice. Specific binding of 3 nM [125I]CLINDE and 1 nM [3H]PK11195 is clearly visible in tissue sections from Tspo+/+ and Tspo+/− mice and is displaceable by the unlabelled ligands. There is no specific binding in Tspo−/− tissue. (g,h) Specific binding using [3H]PK11195 in testicular tissue (g) and kidney tissue (h) (n=3 for each genotype Tspo+/+, Tspo+/− and Tspo−/−). Tspo+/− mice (kidney (Bmax and Kd): 45,361.0 fmol per mg and 5.94 nM; testes: 3,696.0 fmol per mg and 7.32 nM) have approximately half the binding of Tspo+/+mice (kidney: 108,934.0 fmol per mg and 12.90 nM; testes: 4,920.0 fmol per mg and 2.66 nM) while Tspo−/−mice have no appreciable binding. Curves represent non-linear regression of experimentally obtained data points and data are expressed as percentage relative to Tspo+/+ specific binding. Error bars denote standard deviation.](https://figures.cochat.ai/paper-figures/b49242ad71a7481da1038c79e23b1cd0/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-4.jpg)
![Figure 5 Whole-body receptor autoradiography of neonatal mice. Receptor autoradiography using the TSPO ligand [125I]CLINDE on whole bodies of 2-day-old neonatal mice. The autoradiographs show total binding of [125I]CLINDE (3 nM) as well as competitive displacement binding with 10 μM unlabelled CLINDE (CB(CL)), PK11195 (CB(PK)) and PBR111 (CB(PBR)). Specific binding of [125I]CLINDE is clearly visible in the Tspo+/+ mice and is displaceable by all three unlabelled ligands. Non-specific binding is seen in areas of nuchal fat or stomach content.](https://figures.cochat.ai/paper-figures/828414b239864689856398b605c91aa9/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-5.jpg)
![Figure 6 No inducible TSPO ligand binding in Tspo−/− mice. (a,b) TSPO-binding ligands PK11195 and CLINDE/PBR111. (c) Axotomy of the facial nerve induces a retrograde neuronal reaction and highly reproducible microglial activation in the injured facial nucleus. (d) Autoradiography with [3H]PK11195 and [125I]CLINDE and immunohistochemical staining of the microglial activation marker CD11b on consecutive brain sections confirmed the previously reported localized induction of TSPO ligand binding in the injured facial nucleus contemporaneous to the activation of microglia of Tspo+/+ animals. (e) In contrast, no binding of [3H]PK11195 and [125I]CLINDE could be induced in Tspo−/− mice despite the undiminished presence of activated microglia in the injured facial nucleus, thus providing evidence that the high selectivity of [3H]PK11195 and [125I]CLINDE for their respective binding sites on the TSPO is retained in pathologically changed tissue. (f) Immunofluorescent anti-CD11b staining of activated microglia in the injured facial nucleus of Tspo−/− mice revealed no obvious differences in microglial activation, with its characteristic localization of activated, perineuronal microglia, here (g) shown as higher magnification of the above section. Scale bars in (d,e) and the left image of (f) denote 1 mm, and that in the right image of (f) and in (g) 100 μm. The asterixes in (g and f) indicates the soma of neurons.](https://figures.cochat.ai/paper-figures/08195277d3b642a9b15a0cc6240331c0/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-6.jpg)
![Figure 7 PBR/TSPO-expressing brain tumour in global Tspo−/− mouse brain. (a) [18F]PBR111 PET/CT demonstrates a high-contrast signal confined exclusively to the Tspo+/+ brain tumour, while Tspo−/− surrounding brain shows no ligand binding. (b,c) For the same animal shown in (a), in vitro autoradiography with [3H]PK11195 (b) and subsequent immunohistochemical staining with anti-TSPO antibody on the same brain sections (c) confirm that PBR/TSPO ligand binding is strictly limited to the brain tumour region and no PBR/TSPO binding or recognition sites are present in Tspo−/− tissue. Scale bars, 1 mm. The PET images show the time frame from 5 to 10 min after injection and scaling is 0–5.3% ID per cm3 for (a).](https://figures.cochat.ai/paper-figures/a92691c829424c68a30a0871b1244114/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-7.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent genetic mouse models in which TSPO had been deleted tissue specifically and globally have yielded conflicting results regarding steroidogenesis, ranging from no effect on steroidogenesis to severe compromise of ACTH-stimulated production of corticosterone (129–131).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [130]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Assessing mitochondrial dysfunction in cells
Brand, M. D., & Nicholls, D. G. (2011) · Biochemical Journal · doi:10.1042/bj20110162 · Cited by 2,405
The Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536
Current protocols in immunology
Nezlin, R. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,408
Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Self-citationRupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
The peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Self-citationStocco, D. M., Wang, X., Jo, Y., & Manna, P. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0532 · Cited by 538
Enigma of the peripheral benzodiazepine receptor
Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G., & Weizman, A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01424-8 · Cited by 512
Cited by
Items 101–200 of 257
Lee, J., Nam, H., & Yu, S.-W. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.5.262 · Cited by 35
Effects of genetic variants in the TSPO gene on protein structure and stability
Milenkovic, V. M., Bader, S. M., Sudria-Lopez, D., Siebert, R., Brandl, C., Nothdurfter, C., Weber, B. H. F., Rupprecht, R., & Wetzel, C. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195627 · Cited by 36
Translocator protein in the rise and fall of central nervous system neurons
Cheung, G., Lin, Y. C., & Papadopoulos, V. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1210205 · Cited by 36
Targeting mitochondrial energy metabolism with TSPO ligands
Gut, P. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150019 · Cited by 35
Poutiainen, P., Jaronen, M., Quintana, F. J., & Brownell, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00085 · Cited by 37
TSPO protein binding partners in bacteria, animals, and plants
Hiser, C., Montgomery, B. L., & Ferguson-Miller, S. M. (2021) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-021-09905-4 · Cited by 32
Liu, Y.-D., Chang, Y.-H., Xie, X.-T., Wang, X.-Y., Ma, H.-Y., Liu, M.-C., & Zhang, H.-M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05177-w · Cited by 27
TSPO as a target for glioblastoma therapeutics
Werry, E. L., Barron, M. L., & Kassiou, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150015 · Cited by 32
Selvaraj, V., Tu, L. N., & Stocco, D. M. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00091 · Cited by 31
The mitochondrial translocator protein (TSPO): a key multifunctional molecule in the nervous system
Chemali, L. E., Akwa, Y., & Massaad-Massade, L. (2022) · Biochemical Journal · doi:10.1042/bcj20220050 · Cited by 32
The translocator protein (18 kDa) and its role in neuropsychiatric disorders
Barichello, T., Simões, L. R., Collodel, A., Giridharan, V. V., Dal‐Pizzol, F., Macêdo, D. S., & Quevedo, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.010 · Cited by 30
Mitochondrial translocator protein (TSPO), astrocytes and neuroinflammation
Deng, W., & Chechneva, O. V. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.187027 · Cited by 30
Takata, K., Kimura, H., Yanagisawa, D., Harada, K., Nishimura, K., Kitamura, Y., Shimohama, S., & Tooyama, I. (2022) · Molecules · doi:10.3390/molecules27092780 · Cited by 31
Vicente-Rodríguez, M., Singh, N., Turkheimer, F., Peris-Yague, A., Randall, K., Veronese, M., Simmons, C., Karim Haji-Dheere, A., Bordoloi, J., Sander, K., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.05.025 · Cited by 28
Wang, Y., Coughlin, J. M., Ma, S., Endres, C. J., Kassiou, M., Sawa, A., Dannals, R. F., Petri, M., & Pomper, M. G. (2016) · Lupus · doi:10.1177/0961203316657432 · Cited by 28
An Essential Role of Maspin in Embryogenesis and Tumor Suppression
Dzinic, S. H., Bernardo, M. M., Li, X., Fernandez‐Valdivia, R., Ho, Y.-S., Mi, Q., Bandyopadhyay, S., Lonardo, F., Vranić, S., Oliveira, D. S. M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2219 · Cited by 28
Mitochondrial dysfunction and Alzheimer's disease: prospects for therapeutic intervention
Lim, J. W., Lee, J., & Pae, A. N. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.279 · Cited by 28
Mahmud, F. J., Du, Y., Greif, E., Boucher, T., Dannals, R. F., Mathews, W. B., Pomper, M. G., Sysa‐Shah, P., Pate, K. A. M., Lyons, C. E., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01949-4 · Cited by 28
18-kDa translocator protein association complexes in the brain: From structure to function
Costa, B., Pozzo, E. D., & Martini, C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114015 · Cited by 27
Bartos, L. M., Kirchleitner, S. V., Kolabas, Z. I., Quach, S., Beck, A., Lorenz, J., Blobner, J., Müller, S. A., Ulukaya, S., Hoeher, L., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi8986 · Cited by 30
Yu, S.-W., & Kim, L. E. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.158338 · Cited by 27
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis
Martín, A., Vázquez‐Villoldo, N., Gómez‐Vallejo, V., Padró, D., Soria, F. N., Szczupak, B., Plaza‐García, S., Arrieta, A., Reese, T., Llop, J., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3275-3 · Cited by 25
Donat, C. K., Gaber, K., Meixensberger, J., Brust, P., Pinborg, L. H., Hansen, H. H., & Mikkelsen, J. D. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8385-y · Cited by 25
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease
Meyer, C., Niedermeier, T., Feyen, P., Struebing, F. L., Rauchmann, B., Karali, K., Gentz, J., Tillmann, Y., Landgraf, N. F., Rumpf, S.-L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62500-8 · Cited by 24
Self-citationZhang, H., Wang, H., Gao, F., Yang, J. Y., Xu, Y., Fu, Y., Cai, M., Zhang, X., Yang, Q., Tong, K., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.020 · Cited by 24
Shang, C., Yao, R., Guo, Y., Ding, Z.-C., Sun, L., Ran, Y., Xue, R., Wang, H., Zhang, J., Zhang, Y., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119896304 · Cited by 24
The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity
Frison, M., Faccenda, D., Abeti, R., Rigon, M., Strobbe, D., England-Rendon, B. S., Cash, D., Barnes, K., Sadeghian, M., Sajic, M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01050-z · Cited by 26
Dubé, J. J., Collyer, M. L., Trant, S., Toledo, F. G. S., Goodpaster, B. H., Kershaw, E. E., & DeLany, J. P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz272 · Cited by 25
Amhr2-Cre–Mediated Global Tspo Knockout
Fan, J., Campioli, E., Sottas, C. M., Zirkin, B. R., & Papadopoulos, V. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa001 · Cited by 24
Yang, H., Xing, R., Liu, S., Yu, H., & Li, P. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1563621 · Cited by 23
Arif, T., Stern, O., Pittala, S., Caspi, V. C., & Shoshan‐Barmatz, V. (2019) · Cells · doi:10.3390/cells8111330 · Cited by 26
Midzak, A. S., Akula, N., Rone, M. B., & Papadopoulos, V. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.023 · Cited by 20
TSPO Deficiency Exacerbates GSDMD-Mediated Macrophage Pyroptosis in Inflammatory Bowel Disease
Zhang, X., Han, J., Xu, Y., Cai, M., Gao, F., Han, J., Wang, D., Fu, Y., Chen, H., He, W., et al. (2022) · Cells · doi:10.3390/cells11050856 · Cited by 22
Hatty, C. R., & Banati, R. B. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.029 · Cited by 20
Self-citationThe Comprehensive Steroidome in Complete TSPO/PBR Knockout Mice under Basal Conditions
Lière, P., Liu, G. J., Pianos, A., Middleton, R. J., Banati, R. B., & Akwa, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032474 · Cited by 22
Self-citationZhou, J., Zhang, X., Peng, J., Xie, Y., Du, F., Guo, K., Feng, Y., Zhang, L., Chen, L., & Jiang, Y. Q. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134977 · Cited by 21
Milite, C., Barresi, E., Pozzo, E. D., Costa, B., Viviano, M., Porta, A., Messere, A., Sbardella, G., Settimo, F. D., Novellino, E., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01031 · Cited by 19
Rashid, K., Geissl, L., Wolf, A., Karlstetter, M., & Langmann, T. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.10.018 · Cited by 19
A unified structural model of the mammalian translocator protein (TSPO)
Xia, Y., Ledwitch, K. V., Kuenze, G., Duran, A. M., Li, J., Sanders, C. R., Manning, C., & Meiler, J. (2019) · Journal of Biomolecular NMR · doi:10.1007/s10858-019-00257-1 · Cited by 18
Middleton, R. J., Liu, G.-J., & Banati, R. B. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150039 · Cited by 19
Self-citationDetermination and reduction of translocator protein (TSPO) ligand rs6971 discrimination
Sokias, R., Werry, E. L., Chua, S. W., Reekie, T. A., Munoz, L., Wong, E. C. N., Ittner, L. M., & Kassiou, M. (2016) · MedChemComm · doi:10.1039/c6md00523c · Cited by 19
Vicente-Rodríguez, M., Mancuso, R., Peris-Yague, A., Simmons, C., NIMA Consortium, Wlazly, D., Dickinson, A., Foster, A., Knight, C., Leckey, C., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02769-y · Cited by 17
A Protective Role of Translocator Protein in Alzheimer’s Disease Brain
Jung, M. E. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200217105950 · Cited by 17
Thirty years of StAR gazing. Expanding the universe of the steroidogenic acute regulatory protein
Miller, W. L. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0310 · Cited by 22
Epigenetic Silencing of the Human 18 kDa Translocator Protein in a T Cell Leukemia Cell Line
Middleton, R. J., Kam, W. W.-Y., Liu, G.-J., & Banati, R. B. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3385 · Cited by 21
Self-citationXiong, B., Jin, G., Xu, Y., You, W., Luo, Y., Fang, M., Chen, B., Huang, H., Yang, J., Lin, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.692917 · Cited by 16
Werry, E. L., King, V. A., Barron, M. L., Banister, S. D., Sokias, R., & Kassiou, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.09.026 · Cited by 16
Arbo, B. D., Ribeiro, M. F. M., & García‐Segura, L. M. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100943 · Cited by 16
Bréhat, J., Leick, S., Musman, J., Su, J. B., Eychenne, N., Giton, F., Rivard, M., Barel, L.-A., Tropeano, C., Vitarelli, F., et al. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01043-3 · Cited by 15
Tremolanti, C., Germelli, L., Barresi, E., Pozzo, E. D., Simorini, F., Castellano, S., Taliani, S., Settimo, F. D., Martini, C., & Costa, B. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220415120820 · Cited by 15
Klee, K., Storti, F., Barben, M., Samardzija, M., Langmann, T., Dunaief, J. L., & Grimm, C. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107816 · Cited by 15
Fairley, L. H., Lai, K. O., Grimm, A., Eckert, A., & Barron, A. M. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.003 · Cited by 16
TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease
Ceyzériat, K., Badina, A. M., Abjean, L., Meyer, L., Bouteldja, F., Bałkota, M., Amossé, Q., Prudhomme, O., Middleton, R. J., Liu, G.-J., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03583-4 · Cited by 14
Self-citationCheckpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous System
Harrison‐Brown, M., Liu, G. J., & Banati, R. B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122030 · Cited by 17
Self-citationYusuying, S., Yusuyin, S., & Cheng, X. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.09.024 · Cited by 16
Commentary: Amhr2-Cre-Mediated Global Tspo Knockout
Selvaraj, V., Morohaku, K., Koganti, P. P., Zhang, J., He, W., Quirk, S. M., & Stocco, D. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00472 · Cited by 14
Parkin-mediated responses against infection and wound involve TSPO-VDAC complex in Drosophila
Cho, J., Park, J. H., Chung, C. G., Shim, H.-J., Jeon, K. H., Yu, S., & Lee, S. B. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.006 · Cited by 14
MacAskill, M. G., Walton, T., Williams, L. G., Morgan, T. E. F., Alcaide-Corral, C. J., Dweck, M. R., Gray, G. A., Newby, D. E., Lucatelli, C., Sutherland, A. J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217515 · Cited by 13
Liu, J., Hiser, C., Li, F., Hall, R., Garavito, R. M., & Ferguson-Miller, S. M. (2023) · Biochemistry · doi:10.1021/acs.biochem.2c00612 · Cited by 13
Shimoyama, S., Furukawa, T., Ogata, Y., Nikaido, Y., Koga, K., Sakamoto, Y., Ueno, S., & Nakamura, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222861 · Cited by 13
Jurkiewicz, P., Sénicourt, L., Ayeb, H., Lequin, O., Lacapère, J.-J., & Batoko, H. (2020) · iScience · doi:10.1016/j.isci.2020.100889 · Cited by 13
Wu, L.-P., Gong, Z.-F., Wang, H., Zhou, Z.-S., Zhang, M.-M., Liu, C., Ren, H.-M., Yang, J., Han, Y., & Zeng, C.-Y. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0293-x · Cited by 12
STAR/STARD1: A mitochondrial intermembrane space cholesterol shuttle degraded through mitophagy
Koganti, P. P., Zhao, A. H., Kern, M. C., Fassinou, A. C. R., & Selvaraj, V. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2508809122 · Cited by 15
Bader, S. M., Würfel, T., Jahner, T., Nothdurfter, C., Rupprecht, R., Milenkovic, V. M., & Wetzel, C. H. (2023) · Cells · doi:10.3390/cells12060954 · Cited by 13
Oh, C., Song, I. H., Lee, W., Jeon, M., Choi, J., Baek, S., Lee, B. C., Kim, S. E., & Im, H. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.10.001 · Cited by 12
Kapanadze, T. G., Bankstahl, J. P., Wittneben, A., Koestner, W., Ballmaier, M., Gamrekelashvili, J., Krishnasamy, K., Limbourg, A., Roß, T. L., Meyer, G.-J., et al. (2018) · Theranostics · doi:10.7150/thno.27175 · Cited by 11
Tuominen, S., Keller, T., Petruk, N., Lopez‐Picon, F. R., Eichin, D., Löyttyniemi, E., Verhassel, A., Rajander, J., Sandholm, J. A., Tuomela, J. M., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05115-z · Cited by 12
Letter to the Editor: Dubious Conclusions on TSPO Function
Selvaraj, V., & Stocco, D. M. (2018) · Endocrinology · doi:10.1210/en.2018-00052 · Cited by 11
Xiong, B., You, W., Luo, Y., Jin, G., Wu, M., Xu, Y., Yang, J., Huang, H., & Yu, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739618 · Cited by 11
A cholesterol-centric outlook on steroidogenesis
Sidhu, S. K., & Mishra, S. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.05.006 · Cited by 10
Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases
Hector, M., Langmann, T., & Wolf, A. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101249 · Cited by 11
Microglial translocator protein and stressor-related disorder
Kikutani, K., Giga, H., Hosokawa, K., Shime, N., & Aizawa, H. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104855 · Cited by 10
TSPO: an emerging role in appetite for a therapeutically promising biomarker
Wang, J., & Beecher, K. (2021) · Open Biology · doi:10.1098/rsob.210173 · Cited by 10
Jaremko, M., Jaremko, Ł., Giller, K., Becker, S., & Zweckstetter, M. (2015) · Biomolecular NMR Assignments · doi:10.1007/s12104-015-9642-y · Cited by 10
Lack of adrenal TSPO/PBR expression in hamsters reinforces correlation to triglyceride metabolism
Koganti, P. P., & Selvaraj, V. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0189 · Cited by 11
Functional role of translocator protein and its ligands in ocular diseases (Review)
Yu, M., & Zhao, S. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13157 · Cited by 11
Preclinical Evaluation of a Novel 99mTc-Labeled CB86 for Rheumatoid Arthritis Imaging
Liu, P., Wang, T., Yang, R., Dong, W., Wang, Q., Guo, Z., Ma, C., Wang, W., Li, H., & Su, X. (2020) · ACS Omega · doi:10.1021/acsomega.0c04066 · Cited by 8
Jimenez, I. A., Stilin, A. P., Morohaku, K., Hussein, M. H., Koganti, P. P., & Selvaraj, V. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.896951 · Cited by 8
Bréhat, J., Issop, L., & Morin, D. (2024) · Biochimie · doi:10.1016/j.biochi.2024.03.001 · Cited by 9
Membrane-embedded TSPO: an NMR view
Rivière, G., Jaipuria, G., Andreas, L. B., Leonov, A., Giller, K., Becker, S., & Zweckstetter, M. (2020) · European Biophysics Journal · doi:10.1007/s00249-020-01487-0 · Cited by 8
Ground state depletion microscopy as a tool for studying microglia–synapse interactions
Paasila, P. J., Fok, S., Rodriguez, N. F., Sajjan, S., Svahn, A. J., Dennis, C. V., Holsinger, R. M. D., Kril, J. J., Becker, T. S., Banati, R. B., et al. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24819 · Cited by 8
Self-citationBenveniste, H., & Makaryus, R. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001155 · Cited by 8
Morin, D., & Lacapère, J.-J. (2025) · Biochimie · doi:10.1016/j.biochi.2025.08.002 · Cited by 8
Short-term effects of etifoxine on human gut microbiome in healthy men
Manook, A., Baghai, T. C., Riebel, M., Nothdurfter, C., Schwarzbach, J. V., Gessner, A., Rupprecht, R., & Hiergeist, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1188847 · Cited by 7
Rescuing fluoride-induced damages in liver with gamma aminobutyric acid
Yang, H., Xing, R., Liu, S., Yu, H., & Li, P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.015 · Cited by 7
Zhang, Y., He, J., Yang, Z., Zheng, H., Deng, H., Luo, Z., Sun, Q., & Sun, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04134-2 · Cited by 7
Cholesterol-dependent enzyme activity of human TSPO1
Qiu, W., Trinh, T. K. H., Catalano, C., Mehta, A. Y., Desai, U. R., Kellogg, G. E., Hendrickson, W. A., & Guo, Y. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2323045122 · Cited by 8
Morrissey, N. A., Beall, C., & Ellacott, K. L. J. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13027 · Cited by 8
Lu, M., Shi, J., Li, X., Liu, Y., & Liu, Y. (2024) · Food & Function · doi:10.1039/d3fo05302d · Cited by 6
Wetzel, C. H., Bader, S., Jahner, T., Doerfelt, A., Melchner, D., Siegmund, H. I., Siegmund, H., Brochhausen, C., Rupprecht, R., & Milenković, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312882 · Cited by 6
Liu, G.-J., Middleton, R. J., & Banati, R. B. (2017) · Gene · doi:10.1016/j.gene.2017.02.035 · Cited by 7
Self-citationBonsack, F., Foss, C. A., Arbab, A. S., Alleyne, C. H., Pomper, M. G., & Sukumari‐Ramesh, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00066 · Cited by 6
Wen, C., Jiang, Y., Chen, W., Xu, Y., Chen, G., Zhou, Q., Liu, Q., Jiang, H., Liu, Y., Cao, X., et al. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12638 · Cited by 4
Interaction between peripheral and central immune markers in clinical high risk for psychosis
Aji, K. N., Hafizi, S., Silva, T. M. S., Kiang, M., Rusjan, P., Weickert, C. S., & Mizrahi, R. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100636 · Cited by 6
Tuominen, S., Nissi, L., Kukkula, A., Routila, J., Huusko, T., Leivo, I. V. V., Minn, H. R. I., Irjala, H., Löyttyniemi, E., Ventelä, S., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1298333 · Cited by 4
Frison, M., Mallach, A., Kennedy, E., & Campanella, M. (2017) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-319-55539-3_11 · Cited by 5
Regulation of Adrenal Steroidogenesis
Pihlajoki, M., Heikinheimo, M., & Wilson, D. B. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_2 · Cited by 3
Bartolo, N. D., Mortimer, N., Manter, M. A., Sanchez, N., Riley, M. M., O’Malley, T. T., & Hooker, J. M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00607 · Cited by 4
Chemali, L. E., Boutary, S., Liu, S., Liu, G. J., Middleton, R. J., Banati, R. B., Bahrenberg, G., Rupprecht, R., Schumacher, M., & Massaad-Massade, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137327 · Cited by 3
Self-citationPissarek, M. (2018) · World Journal of Neuroscience · doi:10.4236/wjns.2018.81006 · Cited by 3
Metadata
- Authors
- Banati, R. B., Middleton, R. J., Chan, R., Hatty, C. R., Wai-Ying Kam, W., Quin, C., Graeber, M. B., Parmar, A., Zahra, D., Callaghan, P., Fok, S., Howell, N. R., Gregoire, M., Szabo, A., Pham, T., Davis, E., & Liu, G.-J.
- Affiliations
- The University of Sydney (AU)
- Australian Nuclear Science and Technology Organisation (AU)
- Corresponding author
- Banati, Richard B.
- Liu, Guo-Jun
- ORCID
- Venue
- Nature Communications
- Published
- 2014-11-19
- Volume
- 5
- Issue
- 1
- Pages
- 5452-5452
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4263137
- OpenAlex
- W1986304241
- Cited by
- 241
- References
- 43
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 12 · 2023: 15 · 2022: 14 · 2021: 18 · 2020: 30 · 2019: 20 · 2018: 19 · 2017: 26 · 2016: 30 · 2015: 31 · 2014: 2
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- The Australian Nuclear Science and Technology Organisation Institutional Repository (The Australian Nuclear Science and Technology Organisation) (submittedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion)
- Funders
- Australian Nuclear Science and Technology Organisation
- University of Sydney
- Cure Brain Cancer Foundation
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- translocator protein (TSPO), cholesterol transport, steroidogenesis, neuroinflammation biomarkers, PK11195, imidazopyridines, drug selectivity, fertility
- MeSH terms
- Adenosine Triphosphate, Adrenal Glands, Animals, Behavior, Animal, Brain, Cholesterol, Fertility, Kidney, Male, Mice, Inbred C57BL, Pregnenolone, Protoporphyrins, Spleen, Testis, Microglia, Receptors, GABA, Mice, Knockout, Positron-Emission Tomography, Mice, Whole Body Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.